US courts have recently restricted and then paused restrictions on the abortion pill mifepristone, causing legal uncertainty that medical professionals argue undermines patient care. This confusion affects access to telehealth services for obtaining the medication, crucial for both abortion and miscarriage management, potentially limiting reproductive health options nationwide.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



